|
PPP6C expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.90958360235527E-14 |
| Normal-vs-Stage2 |
8.66479999972469E-07 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
4.012000E-01 |
| Stage1-vs-Stage3 |
2.8292999999513E-06 |
| Stage1-vs-Stage4 |
2.01910000052763E-07 |
| Stage2-vs-Stage3 |
7.918400E-02 |
| Stage2-vs-Stage4 |
1.824440E-02 |
| Stage3-vs-Stage4 |
3.246000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.98874250401104E-12 |
| Normal-vs-Asian |
4.385700E-02 |
| Caucasian-vs-AfricanAmerican |
4.637000E-01 |
| Caucasian-vs-Asian |
7.495200E-01 |
| AfricanAmerican-vs-Asian |
4.978000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.66378022470326E-12 |
| Male-vs-Female |
5.841300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.15418827010217E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
3.92279999994471E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.180160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.419400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.511800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.555230E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.995400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.722400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.268200E-02 |
| Normal-vs-Grade 2 |
9.99733629214461E-12 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
1.829960E-01 |
| Grade 1-vs-Grade 3 |
4.183400E-04 |
| Grade 1-vs-Grade 4 |
2.06489999999837E-05 |
| Grade 2-vs-Grade 3 |
5.20900000022806E-07 |
| Grade 2-vs-Grade 4 |
3.34000005430823E-09 |
| Grade 3-vs-Grade 4 |
2.300300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.22049999995433E-07 |
| Normal-vs-ccB subtype |
1.62447832963153E-12 |
| ccA subtype-vs-ccB subtype |
1.21513910045223E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
3.83950000004685E-06 |
| N0-vs-N1 |
4.297600E-02 |
|
|
